Life Sciences Indexes

MSCI Life Sciences Indexes aim to represent the performance of long-term, future-focused themes expected to disrupt the life sciences, biotechnology and pharmaceutical industries. This broad suite of indexes, designed to measure the performance of companies delivering health-focused solutions, can be used to benchmark growth, facilitate portfolio construction, enhance research and support product development.

Target benefits
Leveraging science and technology for healthier outcomes

Get indexes tailored to investor needs

Robust methodology with measures designed to gauge scientific and financial success.

Access industry expertise

MSCI collaborated with Royalty Pharma, investor and biopharmaceutical royalty buyer, to help maintain index relevance.

Choose from broad index suite

Covers oncology and virology as well as key biotech growth areas, with wide applicability.

A world of discoveries

What we offer

Our indexes, which can be customized, focus on preventative and personalized medicines, cancer breakthroughs, new antivirals and digitized assessment, diagnoses and treatments. Royalty Pharma, a funder of biopharmaceutical innovation, informs our design of measures to gauge scientific and financial success.

 

They also have wide applicability:

Investors can use them for investment universe identification and internal research.

Product creators can use them as the basis for ETFs and structured products.

Asset managers can use them to identify potential investment opportunities, fund benchmarking and to conduct internal research.

Corporates and endowments can use them to understand the life sciences landscape and help identify and monitor key trends and competitors.

Want to learn more about Life Sciences Indexes?
Get in touch.

Related to Life Sciences Indexes

Meet our theme experts

See how we mine in-depth research to capture themes as they evolve.

Thematic Exposure Standard

Systematically evaluate, monitor and invest in long-term, structural themes.